| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 38.519 | 46.550 | 57.150 | 61.148 | 63.059 | 64.586 | 88.596 | 101.696 |
| Total Income - EUR | - | 0 | 38.527 | 46.863 | 57.151 | 67.644 | 63.132 | 64.846 | 89.710 | 114.509 |
| Total Expenses - EUR | - | 793 | 20.253 | 23.744 | 28.094 | 34.280 | 37.284 | 27.630 | 36.644 | 64.906 |
| Gross Profit/Loss - EUR | - | -793 | 18.273 | 23.119 | 29.057 | 33.364 | 25.847 | 37.216 | 53.066 | 49.602 |
| Net Profit/Loss - EUR | - | -793 | 17.888 | 22.652 | 28.485 | 32.733 | 25.229 | 36.581 | 52.187 | 46.236 |
| Employees | - | 0 | 0 | 3 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Emirecmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 8.936 | 6.262 | 5.006 | 2.362 | 13.374 | 11.529 | 9.052 | 27.004 |
| Current Assets | - | 79 | 9.124 | 18.005 | 25.214 | 34.209 | 40.034 | 55.136 | 58.140 | 48.378 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 404 | 0 |
| Receivables | - | 0 | 2.942 | 4.020 | 4.840 | 4.857 | 5.722 | 5.228 | 46.183 | 34.365 |
| Cash | - | 79 | 6.182 | 13.985 | 20.373 | 29.352 | 34.312 | 49.908 | 11.553 | 14.013 |
| Shareholders Funds | - | -748 | 17.152 | 22.704 | 28.536 | 32.783 | 25.277 | 36.630 | 52.236 | 46.284 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 827 | 907 | 1.563 | 1.684 | 3.789 | 28.131 | 30.035 | 14.956 | 29.098 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Emirecmed Srl